Ratnakar Securities

Mobile Trading
COMPANY
more from company profile
HomeMarket Info Company Profile Smart Quotes

Smart Quotes

MERCURY LABORATORIES LTD.

NSE : NABSE : 538964ISIN CODE : INE947G01011Industry : Pharmaceuticals & DrugsHouse : Private
BSE915.150 (0 %)
PREV CLOSE ( ) 915.15
OPEN PRICE ( ) 878.90
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 36
TODAY'S LOW / HIGH ( )878.90 929.80
52 WK LOW / HIGH ( ) 7601249
BSE
1D 1M 3M 1Y 3Y 5Y
STOCK SUMMARY
Incorporation Year : 12-02 1982
Management Info
Bharat Mehta - Chairman Rajendra R Shah - Managing Director
Registered Office

Address 18, Shreeji Bhuvan,51, Mangaldas Road,Princess Street,
Mumbai,
Maharashtra-400002

Phone 022 66372841

Email mllbom@mtnl.net.in / mllbrd@mercurylabs.com / secretarial@mercurylabs.com

Website www.mercurylabs.com

Registrars Details
MUFG Intime India Pvt Ltd.
Geetakunu, 1, Bhakti Nagar Society,Behind ABS Tower,Old Padra Road,Vadodara
 Listing : BSE, OTCEI
NEWS
16Nov Mercury Laboratories informs about new
Pursuant to Regulation 47 of SEBI (Listing Obligations and Disclosure Re..
07Oct Mercury Laboratories informs about com
Mercury Laboratories has enclosed a certificate under regulation 74(5) o..
13Sep Mercury Laboratories informs about los
In compliance with Regulation 39(3) of the Securities and Exchange Board..
03Sep Mercury Laboratories informs about new
Mercury Laboratories has enclosed newspaper cuttings for publication of..
05Jul Mercury Laboratories informs about com
Mercury Laboratories has informed that compliance certificate under Reg..
MORE
Financials
in Millions
QTR Sep 24 ANNUAL 24
Net Profit5.0099999999999956.5499999999999
Gross Profit 6.52999999999999 69.2099999999999
Operating Profit 15.17101.2
Net Sales 181.94755.59
MORE
ROLLING FORWARD P/E (EOD)
EVENT CALENDAR
peer group
Neuland Laboratories (BSE)
up  13387.35 (0.74%)
M.Cap ( in Cr)17155.74
Procter&Gamble Healt (BSE)
up  5388.30 (1.36%)
M.Cap ( in Cr)8749.04
Ajanta Pharma (BSE)
up  2846.00 (1.11%)
M.Cap ( in Cr)35546.86
Alivus Life Sciences (BSE)
up  1043.25 (2.20%)
M.Cap ( in Cr)12592.09
Medplus Health Servi (BSE)
up  794.55 (2.46%)
M.Cap ( in Cr)9536.01
MORE
Shareholding Pattern
PROMOTERS 73.66%
NON-INSTITUTION 26.34%
MUTUAL FUNDS/UTI 0%
FI/BANKS/INSURANCE 0%
GOVERNMENT 0%
FII 0%
MORE
Mf Holdings
Scheme NameHold(%)
No Data Found
FAQs
079-49005200 / 01 / 02
info@ratnakarsecurities.com
Download Mobile App

Stock Brokers can accept securities as margin from clients only by way of pledge in the depository system w.e.f. September 1, 2020.

Update your mobile number & email Id with your stock broker/depository participant and receive OTP directly from depository on your email id and/or mobile number to create pledge.

Pay 20% upfront margin of the transaction value to trade in cash market segment.

Investors may please refer to the Exchange's Frequently Asked Questions (FAQs) issued vide circular reference NSE/INSP/45191 dated July 31, 2020 and NSE/INSP/45534 dated August 31, 2020 and other guidelines issued from time to time in this regard.

Check your Securities /MF/ Bonds in the consolidated account statement issued by NSDL/CDSL every month.
.......... Issued in the interest of Investors

INVESTOR CHARTER
products
about us
usefull links
news room

Ratnakar Securities Pvt. Ltd. : SEBI Registration No. of NSE, BSE : INZ000191735 | SEBI Registration No. of NSDL : IN-DP-NSDL-66-88
Ratnakar Commodities Pvt. Ltd : SEBI Registration No. of MCX & NCDEX : INZ000024138
Investor Grievance ID : investorgrievance@ratnakarsecurities.com
Online Dispute Resolution Portal - SMART ODR
To File A Complaint on SCORES Click Here
To Close Account, Please Click Here
For Nomination, Please Click Here
© 2018 Ratnakar Securities Pvt. Ltd. All rights reserved.
Designed, Developed & Content Powered by ●●● Accord Fintech Pvt. Ltd.
CLOSE X

Filing complaints on SCORES Easy & quick

  • > Register on SCORES portal (link:https://scores.gov.in)
  • > Mandatory details for filing complaints on SCORES
    • Name
    • PAN
    • Address
    • Mobile Number
    • E-mail ID
  • > Benefits:
    • Effective communication
    • Speedy redressal of the grievances
CLOSE X

RISK DISCLOSURES ON DERIVATIVES

  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to ₹ 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.
Source: SEBI study dated January 25, 2023 on “Analysis of Profit and Loss of Individual Traders dealing in equity Futures and Options (F&O) Segment”, wherein Aggregate Level findings are based on annual Profit/Loss incurred by individual traders in equity F&O during FY 2021-22.